Compare Agilent Technologies Inc (A) vs McDonald's Corp (MCD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs McDonald's Corp — how do they compare? Agilent Technologies Inc trades at $149.88 (market cap $42.00B), while McDonald's Corp trades at $272.47 (market cap $193.70B). The key difference: McDonald's Corp is far larger — about 4.6× Agilent Technologies Inc's market cap, and McDonald's Corp pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| A | MCD | |
|---|---|---|
Market Cap | $42.00B | $193.70B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $341.06 |
52-Week Low | $110.24 | $262.80 |
Enterprise Value | $43.55B | $247.47B |
Dividend Yield | 0.69% | 2.72% |
Volume | — | 2,230,036 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
McDonald's (MCD) trades at $274.48, down 0.64% for the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $3.41. Revenue grew to $26.89 billion in 2025, supported by a net income margin of 31.72%. Recent news highlights the launch of the 'McDonald's NEXT' strategy focusing on automation and customer experience improvements.
The outlook remains positive with a consensus price target of $322.45, implying significant upside. Strong fundamentals and analyst buy ratings (59.68%) support growth, though risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. The stock offers a solid dividend yield with recent payouts of $1.86 per share.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →
